NAPAJEN

NapaJen Pharma is a clinical-stage biopharmaceutical company developing a new level of oligonucleotide drugs that for the first time can be delivered to target immune cells, overcoming a critical delivery challenge that has limited the development of nucleic acid-based therapeutics to date.

Also known as: NapaJen Pharma, NapaJen Pharma Co., Ltd., NapaJen Pharma, Inc.

Primary location: Seattle United States